Product nameAnti-RPS15 antibody [EPR11105]
See all RPS15 primary antibodies
DescriptionRabbit monoclonal [EPR11105] to RPS15
Tested applicationsSuitable for: WB, ICC/IFmore details
Unsuitable for: Flow Cyt,IHC-P or IP
Species reactivityReacts with: Mouse, Rat, Human
Synthetic peptide corresponding to Human RPS15.
- MCF7, HepG2, A549, and U-87 MG cell lysates; HepG2 cells.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
Storage bufferPreservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant
Concentration information loading...
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab168361 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 17 kDa.|
|ICC/IF||1/100 - 1/250.|
Sequence similaritiesBelongs to the ribosomal protein S19P family.
- Information by UniProt
- 40S ribosomal protein S15 antibody
- Homolog of rat insulinoma antibody
- Insulinoma protein antibody
All lanes : Anti-RPS15 antibody [EPR11105] (ab168361) at 1/1000 dilution
Lane 1 : MCF7 cell lysate
Lane 2 : HepG2 cell lysate
Lane 3 : A549 cell lysate
Lane 4 : U-87 MG cell lysate
Lysates/proteins at 10 µg per lane.
All lanes : Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 17 kDa
Immunofluorescent analysis of HepG2 cells labeling RPS15 with ab168361 at 1/100 dilution.
ab168361 has not yet been referenced specifically in any publications.